Atlas Trials

Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen

Clinical trial NCT01850147 · UNKNOWN

Trial details

NCT number
NCT01850147
Sponsor
Chinese Academy of Medical Sciences
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
CancerLung Cancer
Start date
2013-03-01
Primary completion
2014-10-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.